BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27939504)

  • 1. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
    Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
    Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
    Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
    Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
    Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
    Yamada Y; Jang JH; De Meester I; Baerts L; Vliegen G; Inci I; Yoshino I; Weder W; Jungraithmayr W
    J Heart Lung Transplant; 2016 Apr; 35(4):508-17. PubMed ID: 26755203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.
    Sato S; Kawasaki T; Hatano R; Koyanagi Y; Takahashi Y; Ohnuma K; Morimoto C; Dudek SM; Tatsumi K; Suzuki T
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L562-L573. PubMed ID: 38469626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix.
    Liu Y; Qi Y
    Int Immunopharmacol; 2020 Oct; 87():106774. PubMed ID: 32731178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1.
    Tang Z; Zhai W; Wang Z; Hu Z; Zhang M
    Ann Transplant; 2017 Mar; 22():128-137. PubMed ID: 28265106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide.
    Jungraithmayr W; De Meester I; Matheeussen V; Inci I; Augustyns K; Scharpé S; Weder W; Korom S
    Peptides; 2010 Apr; 31(4):585-91. PubMed ID: 20018218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.
    Jang JH; Baerts L; Waumans Y; De Meester I; Yamada Y; Limani P; Gil-Bazo I; Weder W; Jungraithmayr W
    Clin Exp Metastasis; 2015 Oct; 32(7):677-87. PubMed ID: 26233333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide.
    Zhai W; Jungraithmayr W; De Meester I; Inci I; Augustyns K; Arni S; Hillinger S; Scharpé S; Weder W; Korom S
    Transplantation; 2009 Apr; 87(8):1140-6. PubMed ID: 19384159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The depletion of donor macrophages reduces ischaemia-reperfusion injury after mouse lung transplantation.
    Tsushima Y; Jang JH; Yamada Y; Schwendener R; Suzuki K; Weder W; Jungraithmayr W
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):703-9. PubMed ID: 24113322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD26 as a target against fibrous formation in chronic airway rejection lesions.
    Jungraithmayr W; Yamada Y; Haberecker M; Breuer E; Schuurmans M; Dubs L; Itani S; Janker F; Weder W; Schmitt-Opitz I; Jang JH
    Life Sci; 2021 Aug; 278():119496. PubMed ID: 33894269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of remote lung injury following liver ischemia/reperfusion: Possible protective role of vildagliptin.
    Sherif IO; Al-Shaalan NH
    Int Immunopharmacol; 2021 Feb; 91():107305. PubMed ID: 33388732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
    Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
    Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.
    Zebedin-Brandl E; Themanns M; Kazemi Z; Nasrollahi-Shirazi S; Mussbacher M; Heyes E; Meissl K; Prchal-Murphy M; Strohmaier W; Krumpl G; Freissmuth M
    J Mol Med (Berl); 2020 Feb; 98(2):233-243. PubMed ID: 31872285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice.
    Tian W; Liu Y; Zhang B; Dai X; Li G; Li X; Zhang Z; Du C; Wang H
    Lung; 2015 Feb; 193(1):85-95. PubMed ID: 25344633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
    Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
    Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.
    Chua S; Lee FY; Tsai TH; Sheu JJ; Leu S; Sun CK; Chen YL; Chang HW; Chai HT; Liu CF; Lu HI; Yip HK
    J Transl Med; 2014 Dec; 12():357. PubMed ID: 25496837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.